Description
Global Medicated Confectionery Market Research Report—Forecast till 2026
Global Medicated Confectionery Market Overview
Global Medicated Confectionery Market is anticipated to witness a significant CAGR of 4.51% to surpass USD 6,861.0 Million during the review period. Medicated confectionery consists widely used in the manufacturing of drugs for many conditions such as minor throat irritations, coughs, colds, respiratory tract congestion, and allergies.
The major competitors of medicated confectionery are introducing new products and market strategies to gain competitive advantage globally. Additionally, due to the current outbreak of Covid-19, the governments in various countries have ordered the manufacturing of only essential products and medicated confectionery does not fall under essential commodities is expected to limit the market for some extent of time.
Global Medicated Confectionery Market is estimated to register a notable market growth during the review period owing to the rising consumption of confectionery products over the last few years. The global market growth is driven by product inventions based on formulations and innovative packaging.
The popularity of medicated confectionery has increased because of the retention time of the dosage form in the oral cavity which bolsters bioavailability, minimizes gastric irritation, and enhances metabolism rate.
The rapidly expanding organized retail sector is expected to propel the global medicated confectionery market during the forecast period. However, the rising obesity and diabetes among the consumers are expected to hinder the growth of the global medicated confectionery market during the review period.
Market Segmentation
Global Medicated Confectionery Market by Type, Category, and distribution channel. Based on type segment the global market has been classified into Hard Candies, Soft Confectioneries, Chewing Gums, Gummies & Jellies, Pastilles, and Others. In terms of the Category segment, the market has been bifurcated into Sugar-Based, Sugar-Free.
In terms of distribution channel, the global medicated confectionery market has been categorized into store-based and non-store based. The store-based segment is further divided into supermarkets & hypermarkets, specialty stores, discount stores, and others.
The store-based segment is estimated to lead the global market and reach USD 5,595.6 million during the review period. The non-store-based segment is estimated to exhibit a significant CAGR of 4.59% during 2020-2026.
Regional Analysis
Geographically, the Global Medicated Confectionery Market has been spread across North America, Europe, Asia Pacific, and the Rest of the world.
Asia-Pacific is expected to command the market with a projected CAGR of 4.69% during the review period of 2020 to 2026. In 2019, the region accounted for 41.84% of the global market.
China contributes the leading medical confectionery market to the growth of the Asia-Pacific market. The regional market is attributed to the growing organized retail sector in the developing economies of Asia-Pacific during the forecast period.
Major Players
The Key players in the global medicated confectionery market are Procter & Gamble Co. (US), Reckitt Benckiser Group PLC (UK), Mondelēz International, Inc. (US), Mars, Incorporated (US), Perfetti Van Mell (Netherlands), Herbion International Inc. (US), LanesHealth (UK), Ricola (Switzerland), Lofthouse of Fleetwood Ltd (UK), Baker Perkins (UK), and UHA Mikakuto (Japan).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.
Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Global Dairy Ingredients Market–Analysis of Market Size, Share & Trends for 2016 – 2019 and Forecasts to 2030
Table of Contents
TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 MARKET ATTRACTIVENESS ANALYSIS 14
1.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET, BY PRODUCT TYPE 15
1.1.2 GLOBAL MEDICATED CONFECTIONERY MARKET, BY CATEGORY 16
1.1.3 GLOBAL MEDICATED CONFECTIONERY MARKET, BY DISTRIBUTION CHANNEL 17
1.1.4 GLOBAL MEDICATED CONFECTIONERY MARKET, BY REGION 18
2 MARKET INTRODUCTION
2.1 DEFINITION 19
2.2 SCOPE OF THE STUDY 19
2.3 RESEARCH OBJECTIVE 19
2.4 MARKET STRUCTURE 20
2.5 KEY BUYING CRITERIA 20
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS 21
3.2 PRIMARY RESEARCH 22
3.3 SECONDARY RESEARCH 23
3.4 MARKET SIZE ESTIMATION 23
3.5 FORECAST MODEL 25
3.6 LIST OF ASSUMPTIONS 26
4 MARKET INSIGHTS
5 MARKET DYNAMICS
5.1 INTRODUCTION 29
5.2 DRIVERS 30
5.2.1 HEALTH BENEFITS ASSOCIATED WITH MEDICATED CONFECTIONERY 30
5.2.2 MOUNTING GROWTH OF ORGANIZED RETAIL SECTOR IN ASIA-PACIFIC REGION 30
5.2.3 DRIVERS IMPACT ANALYSIS 31
5.3 RESTRAINTS 31
5.3.1 INCREASING OBESITY AND DIABETIC PATIENT 31
5.3.2 RESTRAINTS IMPACT ANALYSIS 32
5.4 OPPORTUNITIES 32
5.4.1 INCREASING DEMAND FOR SUGAR-FREE CONFECTIONERY 32
5.4.2 NEW PRODUCT DEVELOPMENT 33
6 MARKET FACTOR ANALYSIS
6.1 VALUE CHAIN ANALYSIS 34
6.1.1 RAW MATERIAL PROCUREMENT 35
6.1.2 PROCESSING 35
6.1.3 PACKAGING 35
6.2 SUPPLY CHAIN ANALYSIS 36
6.3 PORTER’S FIVE FORCES MODEL 37
6.3.1 THREAT OF NEW ENTRANTS 37
6.3.2 BARGAINING POWER OF SUPPLIERS 38
6.3.3 BARGAINING POWER OF BUYERS 38
6.3.4 THREAT OF SUBSTITUTES 38
6.3.5 INTENSITY OF RIVALRY 38
7 IMPACT OF COVID-19 ON THE GLOBAL MEDICATED CONFECTIONARY MARKET
8 GLOBAL MEDICATED CONFECTIONERY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW 41
8.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET ESTIMATES & FORECAST, BY PRODUCT TYPE, 2018–2026 42
8.2 HARD CANDIES 42
8.2.1 HARD CANDIES: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 43
8.3 SOFT CONFECTIONERIES 43
8.3.1 SOFT CONFECTIONERIES: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 44
9 GLOBAL MEDICATED CONFECTIONERY MARKET, BY CATEGORY
9.1 OVERVIEW 45
9.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET ESTIMATES & FORECAST, BY CATEGORY, 2018–2026 46
9.2 SUGAR-BASED 46
9.2.1 SUGAR-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 46
9.3 SUGAR FREE 47
9.3.1 SUGAR FREE: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 47
10 GLOBAL MEDICATED CONFECTIONERY MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW 48
10.1.1 GLOBAL MEDICATED CONFECTIONERY MARKET ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2018–2026 49
10.2 STORE-BASED 49
10.2.1 STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 50
10.3 NON-STORE-BASED 50
10.3.1 NON-STORE-BASED: MARKET ESTIMATES & FORECAST, BY REGION, 2018–2026 50
11 GLOBAL MEDICATED CONFECTIONERY MARKET, BY REGION
11.1 OVERVIEW 51
11.2 NORTH AMERICA 53
11.2.1 US 55
11.2.2 CANADA 57
11.2.3 MEXICO 58
11.3 EUROPE 60
11.3.1 UK 62
11.3.2 GERMANY 64
11.3.3 FRANCE 65
11.3.4 ITALY 67
11.3.5 SPAIN 68
11.3.6 REST OF EUROPE 70
11.4 ASIA-PACIFIC 72
11.4.1 CHINA 74
11.4.2 JAPAN 76
11.4.3 INDIA 77
11.4.4 AUSTRALIA & NEW ZEALAND 79
11.4.5 REST OF ASIA-PACIFIC 80
11.5 REST OF THE WORLD 82
11.5.1 SOUTH AMERICA 84
11.5.2 MIDDLE EAST 86
11.5.3 AFRICA 87
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION 89
12.1.1 MARKET STRATEGY ANALYSIS 89
12.2 COMPETITIVE BENCHMARKING 90
12.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 91
12.3.1 PRODUCT LAUNCH 91
12.3.2 EXPANSIONS 91
12.3.3 MERGER 91
13 COMPANY PROFILES
13.1 PROCTER & GAMBLE CO. 92
13.1.1 COMPANY OVERVIEW 92
13.1.2 FINANCIAL OVERVIEW 92
13.1.3 PRODUCTS OFFERED 93
13.1.4 KEY DEVELOPMENTS 93
13.1.5 SWOT ANALYSIS 94
13.1.6 KEY STRATEGIES 94
13.2 RECKITT BENCKISER GROUP PLC 95
13.2.1 COMPANY OVERVIEW 95
13.2.2 FINANCIAL OVERVIEW 95
13.2.3 PRODUCTS OFFERED 96
13.2.4 KEY DEVELOPMENTS 96
13.2.5 SWOT ANALYSIS 97
13.2.6 KEY STRATEGIES 97
13.3 MONDELĒZ INTERNATIONAL, INC. 98
13.3.1 COMPANY OVERVIEW 98
13.3.2 FINANCIAL OVERVIEW 98
13.3.3 PRODUCTS OFFERED 99
13.3.4 KEY DEVELOPMENTS 99
13.3.5 SWOT ANALYSIS 100
13.3.6 KEY STRATEGIES 100
13.4 MARS, INCORPORATED 101
13.4.1 COMPANY OVERVIEW 101
13.4.2 FINANCIAL OVERVIEW 101
13.4.3 PRODUCTS OFFERED 101
13.4.4 KEY DEVELOPMENTS 102
13.4.5 SWOT ANALYSIS 102
13.4.6 KEY STRATEGIES 102
13.5 PERFETTI VAN MELL 103
13.5.1 COMPANY OVERVIEW 103
13.5.2 FINANCIAL OVERVIEW 103
13.5.3 PRODUCTS OFFERED 103
13.5.4 KEY DEVELOPMENTS 103
13.5.5 SWOT ANALYSIS 104
13.5.6 KEY STRATEGIES 104
13.6 HERBION INTERNATIONAL INC. 105
13.6.1 COMPANY OVERVIEW 105
13.6.2 FINANCIAL OVERVIEW 105
13.6.3 PRODUCTS OFFERED 105
13.6.4 KEY DEVELOPMENTS 105
13.6.5 KEY STRATEGIES 105
13.7 LANESHEALTH 106
13.7.1 COMPANY OVERVIEW 106
13.7.2 FINANCIAL OVERVIEW 106
13.7.3 PRODUCTS OFFERED 106
13.7.4 KEY DEVELOPMENTS 106
13.7.5 KEY STRATEGIES 106
13.8 RICOLA 107
13.8.1 COMPANY OVERVIEW 107
13.8.2 FINANCIAL OVERVIEW 107
13.8.3 PRODUCTS OFFERED 107
13.8.4 KEY DEVELOPMENTS 107
13.8.5 KEY STRATEGIES 107
13.9 LOFTHOUSE OF FLEETWOOD LTD. 108
13.9.1 COMPANY OVERVIEW 108
13.9.2 FINANCIAL OVERVIEW 108
13.9.3 PRODUCTS OFFERED 108
13.9.4 KEY DEVELOPMENTS 109
13.9.5 KEY STRATEGIES 109
13.10 BAKER PERKINS 110
13.10.1 COMPANY OVERVIEW 110
13.10.2 FINANCIAL OVERVIEW 110
13.10.3 PRODUCTS OFFERED 110
13.10.4 KEY DEVELOPMENTS 110
13.10.5 KEY STRATEGIES 110
13.11 UHA MIKAKUTO 111
13.11.1 COMPANY OVERVIEW 111
13.11.2 FINANCIAL OVERVIEW 111
13.11.3 PRODUCTS OFFERED 111
13.11.4 KEY DEVELOPMENTS 111
13.11.5 KEY STRATEGIES 111
14 REFERENCES
